Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New trends in innovative vaccine development against Actinobacillus pleuropneumoniae.

Veterinary microbiology - 1 Apr 2018

Loera-Muro Abraham, Angulo Carlos

Abstract excerpt

Actinobacillus pleuropneumoniae is the etiological agent of porcine pleuropneumonia, a respiratory disease leading to severe economic losses in the swine industry. The most widely used commercial vaccines are bacterins comprising inactivated whole cells of A. pleuropneumoniae but these have only been partially effective in preventing disease. Innovative immuno-prophylactic preparations of A. pleuropneumoniae...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Actinobacillus Infections
Share to Actinobacillus pleuropneumoniae
Share to Antigens, Bacterial

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Bacterial Vaccines

Share to Drug Delivery Systems

Share to Swine Diseases

Share to Vaccines, Attenuated

Share to Vaccines, Subunit

Source

Identifiers

PMID: 29615259
DOI: 10.1016/j.vetmic.2018.02.028

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New trends in innovative vaccine development against Actinobacillus pleuropneumoniae.PMID 29615259Read ↗

Comparative genome analyses to understand the population biology and virulence of the pig pathogen Actinobacillus pleuropneumoniaeSemantic proximity Read ↗

Characterization and immunogenicity of an apxIA mutant of Actinobacillus pleuropneumoniae.Semantic proximity Read ↗

Potential use an Actinobacillus pleuropneumoniae double mutant strain DeltaapxIICDeltaapxIVA as live vaccine that allows serological differentiation between vaccinated and infected animals.Semantic proximity Read ↗

Development of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae infection.Semantic proximity Read ↗

Recombinant tandem epitope vaccination provides cross protection against Actinobacillus pleuropneumoniae challenge in miceSemantic proximity Read ↗

Use of an Actinobacillus pleuropneumoniae multiple mutant as a vaccine that allows differentiation of vaccinated and infected animals.Semantic proximity Read ↗

Construction and immunogenicity of a ∆apxIC/ompP2 mutant of Actinobacillus pleuropneumoniae and Haemophilus parasuis.Semantic proximity Read ↗

Virulence in Actinobacillus pleuropneumoniae and RTX toxins.Semantic proximity Read ↗

<i>In-silico</i> prediction and modeling of ApxA exotoxins of <i>Actinobacillus pleuropneumoniae:</i> ApxIA, -IIA, -IIIA and -IVASemantic proximity Read ↗

Development and use of a multiplex polymerase chain reaction assay based on Apx toxin genes for genotyping of Actinobacillus pleuropneumoniae isolates.Semantic proximity Read ↗

Update on the development of Group A Streptococcus vaccinesSemantic proximity Read ↗

Comparison of molecular serotyping methods for Actinobacillus pleuropneumoniae and analysis of atypical serotypes detected in routine diagnosticsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.